March 28, 2013 (by Frank Kollar)
After rising from $53.00 in early January, Market Vectors Biotech (NYSE: BBH) hit a new closing high on March 15th at $63.20.
The following day the widely traded ETF suffered a bearish outside reversal day and two day later reached an intra-day correction low of $61.35.
BBH has been erasing those losses, modest though they were, in the seven trading days since. The ETF is now trading only a fraction below its March 15th intra-day high at $63.36.
As this analysis was being written, BBH was trading at $63.20.
Chart Courtesy of StockCharts.com
BBH has a good chance of posting a new high during the next few sessions. If it can close above $64.00 a share. look for a breakout rally over coming weeks.
There is no target that we can see as the ETF is at new highs. We would set a 5% trailing stop if this trade is taken.
The Fibtimer.com (http://www.fibtimer.com) ETF Timing Strategy does have a current position in Market Vectors Biotech.